Professor Gerry Fowkes
Emeritus Professor of Epidemiology, Usher Institute, College of Medicine and Veterinary Medicine, UK
About this event
- Date and time Wed 1 Sep 2021 from 2:30pm to 4 Sep 2021 at 12:30pm
- Location Online
- Organised by Vascular, Lipid and Metabolic Medicine Section, The European Society of Vascular Medicine
This free 4-day virtual conference will provide evidence-based lectures from highly respected international experts on best practice for the peripheral vascular disease (PVD) patient, along with a comprehensive review of PVD aspects, covering peripheral artery disease, venous disease and lymphology. And update on the latest evidence in epidemiology, diagnosis and management.
The extensive 4-day programme featuring eminent international speakers will cover:
- The latest advances in:
- vascular and metabolic medicine
- the management of hypercholesterolemia
- Best current practice and/or current best evidence-based practice in:
- the prevention and treatment of venous thromboembolic disease
- peripheral arterial disease
- Raynauds phenomenon
- the prevention and treatment of lipid-lowering in peripheral arterial disease
- Lymphatic disease
- Best current use of antithrombotics in peripheral vascular disease
- The impact of COVID-19 on microcirculation disorders
- Current challenges in revascularisation
This is a unique multidisciplinary virtual conference providing education for physicians, surgeons and interventional radiologists.
CPD learning accredited for all 4 days.
This meeting has been partially supported by Bristol Myers Squibb in the form of an educational grant. We would also like to thank our sponsors Amgen, Bayer (Schweiz) AG, BIOTRONIK UK Ltd, Boston Scientific, Medi Ireland (Royale Distributing Agency Ltd), Sigvaris AG, Thuasne and Viatris for their support of this meeting.
Please note that none of the companies listed above have had any influence or involvement over the scientific programme, organisation or content of this meeting.
Join in the conversation online using #RSMVascular
Follow us on Twitter: @RoySocMed, @_ESVM
Key speakers
Dr Fredrick Wigley
Physician-Scientist and Director, The Johns Hopkins Scleroderma Center, USA
Dr Marianne Brodmann
Head of Division of Angiology and Head of Clinical Research, Division of Angiology, Medical University of Graz, Austria
Professor Alberico Catapano
Professor of Pharmacology and Director, Center of Epidemiology and Preventive Pharmacology, University of Milan, the Laboratory of Lipoproteins, Immunity and Atherosclerosis, the Center for the Study of Atherosclerosis, Bassini Hospital, and Multimedica IRCCS Milan, Italy
Dr Sonia Anand
Professor of Medicine and Epidemiology, McMaster University, and Director of the Population Genomics Program and a vascular medicine specialist, Hamilton Health Services and McMaster University, Canada
Agenda
View the programme - Wednesday 1 September 2021 (UK time)
Symposium one: Introduction
Opening ceremony and welcome
Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, UK and Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK
Symposium two: Debate - Vascular and metabolic medicine: Where are we going?
Chaired by: Professor Gerit-Holger Schernthaner, Austria
Discussion one
Professor Christian Heiss, Professor of Cardiovascular Medicine, University of Surrey, UK
Discussion two
Professor Andrew J Krentz, Visiting Professor, School of Population Health Sciences, University College London, UK
Comfort break
Symposium three: Venous thrombo-embolic disease
Chaired by: Professor Adriana Visona, Italy and Dr Paul Flynn, UK
This session has been sponsored by Viatris. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.
Risk of venous thromboembolism in patients with COVID‐19
Professor Ay Cihan, Austria
VTE in pregnancy
Professor Manuel Monreal Bosch, Spain
VTE: Extended treatment
Professor Paolo Prandoni, Italy
Thrombolysis in the prevention of PTS
Associate Professor Niels Baekgaard, Denmark
Discussion
Symposium four: Young academy of the ESVM session
Chaired by: Dr Thomas Gary, Austria and Dr Daniel Swerdlow, UK
Thrombotic events after COVID 19 vaccination: pathophysiology and treatment options
Dr Thomas Gary, Austria
Risk factors management in vascular patients: An ICP model
Paola Bigolin, Italy
The importance of early diagnosis to improve outcome in diabetic feet
Dr Rumaisa Banatwalla, UK
Symposium five: Plenary - New frontiers in the management of hypercholesterolemia
Chaired by: Dr Dan-Mircea Olinic, Romania and Dr Jaimini Cegla, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust, UK
New frontiers in the management of hypercholesterolemia
Professor Alberto Zambon, Italy
Comfort break
Vascular, Lipid and Metabolic Medicine Section AGM
Members only
Vascular, Lipid and Metabolic Medicine Section AGM
Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK
Close of meeting
View the programme - Thursday 2 September 2021 (UK time)
Welcome and introduction
Symposium six: Aspects of peripheral arterial disease
Chaired by: Dr Dragan Vasic, Serbia and Professor Christian Heiss, Professor of Cardiovascular Medicine, University of Surrey, UK
The PAD iceberg: Epidemiology and under-diagnosis
Professor Gerry Fowkes, Emeritus Professor of Epidemiology, University of Edinburgh, UK
The current role of DCB (Still state of the Art?) in the treatment of lower limb peripheral artery disease
Dr Ralf Langhoff, Medical Director, Head of Department
Angiology/Vascular Medicine, Berlin, Germany
Exercise in Peripheral Arterial Disease
Professor Lucia Mazzolai
Peri-interventional care of PAD patients
Dr Ulrich Frank, Switzerland
Symposium seven - Plenary: Antithrombotics in PAD
Chaired by: Professor Karel Roztocil, Czech Republic and Dr Handrean Soran, Consultant Physician and Endocrinologist and Honorary Senior Lecturer, Manchester University Hospitals NHS Foundation Trust, UK
This session has been sponsored by Bayer (Schweiz) AG. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.
Antithrombotics in PAD
Professor Sonia Anand, Canada
Symposium eight - Plenary: Lecture under joint auspices of IUA/ESVM
Chaired by: Vinko Boc, Specialist of Cardiology and Vascular Medicine, Head of Catheter Laboratory Unit Department of Vascular Diseases University Clinical Centre Ljubljana, Slovenia, Professor Sean Caroll and Dr Pier Luigi Antignani, Director, Vascular Centre, Nuova Villa Claudia, Rome, Italy
Arterial atherothrombotic and venous thromboembolic disease - the same entity with two different faces
Professor Pavel Poredos, Slovenia
The pharmacological treatment of AAA: can it avoid progression ?
Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK
Comfort break
Symposium nine: ESC Aorta and PAD W/G Session
Chaired by: Professor Lucia Mazzolai, Switzerland and Professor Gerard Stansby, UK
Should we screen for AAA ?
Professor Victor Aboyans, France
Endovascular or surgical repair ?
Dr Henrik Sillesen, Denmark
What follow up after a AAA intervention?
Professor Daniel Staub, Switzerland
Discussion
Comfort break
Vascular, Lipid and Metabolic Medicine Section Council Meeting
Council members only
Vascular, Lipid and Metabolic Medicine Section Council Meeting
Close of meeting
View the programme - Friday 3 September 2021 (UK time)
Welcome and introduction
Symposium ten: Microcirculation
Chaired by: Professor Agata Stanek, Poland and Professor Faisel Khan, Professor of Cardiovascular Sciences, University of Dundee, UK
COVID-19 and the cardiovascular system
Professor Tomasz Guzik, UK
Endothelial dysfunction in COVID-19
Dr Andreas Flammer, Switzerland
Microcirculation in cardiometabolic disease
Professor Coen Stehouwer, Chair, Department of Internal Medicine
Maastricht University Medical Centre+, Maastricht, the Netherlands
Panel discussion
Symposium eleven - Plenary: Raynauds phenomenon
Chaired by: Professor Patrick Carpentier, France and Dr John Pauling, UK
Raynauds phenomenon
Professor Fred Wigley, USA
Comfort break
Symposium twelve: Diabetes and PAD/diabetic foot
Chaired by: Dr Zsolt Pecsvarady, Hungary and Professor Andrew J Krentz, Visiting Professor, School of Population Health Sciences, University College London, UK
Death rate after foot ulcer
Dr Matthew Young, UK
Stem cell therapies for diabetic wounds
Dr Shibashish Giri, Germany
Community based interventions
Dr Adrian Heald, UK and Dr George Dunn, UK
Inpatient management of diabetic foot disease
Professor Gerry Rayman, UK
Symposium thirteen - Plenary: Lipid lowering in PAD: An effective approach for treatment and prevention
Chaired by: Dr Caitriona Canning, Ireland and Dr Dimitri Mikhailidis, Reader and Honorary Consultant, Clinical Biochemistry, Royal Free Hospital, University College London, UK
Lipid lowering in PAD: An effective approach for treatment and prevention
Professor Alberico Catapano, Italy
This session has been sponsored by Amgen. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.
Comfort break
European Society for Vascular Medicine AGM
ESVM members only
European Society for Vascular Medicine AGM
Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, Dr Sonia Arnand and Professor Isabelle Quéré
Close of meeting
View the programme - Saturday 4 September 2021 (UK time)
Welcome and introduction
Symposium fourteen: Honorary fellowship award
Chaired by Professor Anders Gottsater, Sweden and Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, UK
Diabetes and venous diseases - is there a link?
Professor Karel Roztocil, Czech Republic
Symposium fifteen: VLMM CV Symposium: Challenges in revascularisation
Chaired by: Professor Sigrid Nikol and Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine
When to revascularise acute DVT?
Associate Professor Oliver Schlager, Austria
Challenges in Pelvic vein disease
Dr Michael Lichtenberg, Germany
The calcified lesion and atherectomy
Associate Professor Juraj Madaric, Head of Department of Angiology, National Institute
of Cardiovascular Diseases, Bratislava, Slovakia
Still 'endovascular first' for effective PAD treatment
Dr Marianne Brodmann, Austria
Panel discussion
Comfort break
Symposium sixteen: Lymphatic disease
Chaired by: Dr Dimakakos Evangelos, Head of the Vascular-Lymphology, European Teaching Center of UEMS for Angiology, Vascular Medicine 3rd University Inyernal Medicine Hospital ‘SOTIRIA’, Greece and Dr Uazman Alam, UK
This session has been sponsored by Thuasne. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.
From an epidemiologic point of view: What is Lymphedema? How to understand the controversies around the definition
Professor Christine Moffatt, UK
From a clinical/classification point of view: What is Lymphedema? How to understand the controversies around the definition
Dr Kristiana Gordon, Consultant in Dermatology & Lymphovascular Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK
New therapeutic options: Genetics in primary lymphoedema - Impact on management
Professor Miikka Vikkula, Belgium and Professor Isabelle Queré, France
New therapeutic options: Surgery in primary lymphoedema - Specific issues
Dr Francesco Boccardo, Italy
Compression: Concepts and innovation in Lymphology
Professor Isabelle Queré, France
Symposium seventeen: Closing ceremony and thanks
Closing ceremony and thanks
Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine
Close of meeting
Sponsors
Location
Online
